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As genes that confer increased risk for autism
spectrum disorder (ASD) are identified, a crucial
next step is to determine how these risk factors
impact brain structure and function and contribute
to disorder heterogeneity. With three converging
lines of evidence, we show that a common, functional
ASD risk variant in the Met Receptor Tyrosine Kinase
(MET) gene is a potent modulator of key social brain
circuitry in children and adolescentswith andwithout
ASD. MET risk genotype predicted atypical fMRI
activation and deactivation patterns to social stimuli
(i.e., emotional faces), as well as reduced functional
and structural connectivity in temporo-parietal
regions known to have high MET expression, partic-
ularly within the default mode network. Notably,
these effects were more pronounced in individuals
with ASD. These findings highlight how genetic
stratification may reduce heterogeneity and help
elucidate the biological basis of complex neuropsy-
chiatric disorders such as ASD.
INTRODUCTION
Over the past decade significant strides have beenmade toward
understanding the genetic basis of autism spectrum disorder
(ASD) (see Geschwind, 2011 and State and Levitt, 2011 for
review), a highly heritable psychiatric disorder (Bailey et al.,
1995; Rosenberg et al., 2009; Hallmayer et al., 2011). Yet, due
to the complexities of both ASD genetic architecture and
brain-behavior relationships, great challenges remain in delin-
eating how ASD risk genes shape the circuits underlying social
behavior. Brain imaging studies have demonstrated that indi-
vidual variation in task-based fMRI activation patterns, resting
state functional connectivity (rs-fcMRI), and structural connec-
tivity measures has a strong genetic component (Chiang et al.,904 Neuron 75, 904–915, September 6, 2012 ª2012 Elsevier Inc.2011; Kochunov et al., 2010; Fornito et al., 2011; Glahn et al.,
2010; Koten et al., 2009) and is altered in ASD (see Di Martino
et al., 2009 and Vissers et al., 2012 for review). Thus, neuroimag-
ing endophenotypes are ideal for bridging the gap in our under-
standing of how genetic risk impacts brain circuitry. Yet, both
behavioral and imaging phenotypes in ASD present significant
heterogeneity and substantial overlap with typical populations,
often leading to discrepant findings (e.g., Cheng et al., 2010). A
critical question then is how genetic variability underlies pheno-
typic heterogeneity and, consequently, whether stratifying by
genetic risk factors can improve our understanding of the neuro-
biology of ASD.
Although recent estimates suggest that hundreds of genes are
likely to contribute to ASD risk (Buxbaum et al., 2012), the vast
majority of evidence comes from rare mutations, such as the
recently described copy number variants (CNVs) (Marshall
et al., 2008; Pinto et al., 2010) and de novo single-nucleotide
variants (SNVs) (Sanders et al., 2012; O’Roak et al., 2012; Neale
et al., 2012; Iossifov et al., 2012). These mutations are rare
(occurring in less than 1% of the population), may be unique
to the individual, and are estimated to collectively impact
10%–20% of the ASD-diagnosed population. Therefore, while
de novo events are conceptually important for understanding
the many potential biological routes to ASD etiology, their utility
for understanding phenotypic heterogeneity across the ASD
population remains to be determined. Perhaps due to clinical
heterogeneity, small estimated effect sizes, and limited statis-
tical power, genome-wide association (GWA) studies focusing
on common variants (>5% allele frequency) have failed to yield
conclusive evidence for any specific common variants influ-
encing ASD risk when pooling data across studies (Wang
et al., 2009; Weiss et al., 2009; Anney et al., 2010). However,
a few notable ASD candidate genes with common variants—
namely, contactin-associated protein-like 2 (CNTNAP2) and
Met Receptor Tyrosine Kinase (MET)—have been identified
using large samples. Importantly, these variants have been
replicated in independent cohorts, and follow-up studies have
characterized the functional consequences of the genetic variant
on gene or protein expression, providing additional support
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databases: SFARI Gene Base, https://gene.sfari.org/autdb/
GS_Home.do; and Autism Knowledge Base, Xu et al., 2012).
Interestingly, common variation in CNTNAP2 has been previ-
ously found to impact functional (Scott-Van Zeeland et al.,
2010) and structural (Dennis et al., 2011) brain connectivity in
healthy control participants. Despite a replicated common
variant (MET rs1858830; Campbell et al., 2006, 2008; Jackson
et al., 2009) and convergent lines of molecular and cellular
evidence for autism risk (Judson et al., 2011b), the impact of
MET on human brain circuitry has not yet been examined.
MET is one of multiple genes encoding proteins in the ERK/
PI3K signaling pathway, including PTEN, NF1, and TSC1, that
have been implicated in syndromic and idiopathic causes of
ASD (Levitt and Campbell, 2009). In the forebrain, MET gene
and protein expression is highly regulated in excitatory projec-
tion neurons during synapse formation (Judson et al., 2009,
2011a; Eagleson et al., 2011). MET is expressed widely in the
mouse neocortex (Judson et al., 2009), but in monkeys (Judson
et al., 2011a) and humans (Mukamel et al., 2011), it is far more
limited, restricted to regions of temporal, occipital, and medial
parietal cortex—regions that contain circuits underlying the pro-
cessing of socially relevant information. The clinical relevance of
MET cortical expression has been exemplified by postmortem
brain studies, whereby individuals with ASD displayed 50%
lower levels of MET protein in superior temporal gyrus (Campbell
et al., 2007) and did not display the same temporo-frontal differ-
ential expression pattern as control subjects (Voineagu et al.,
2011).
Three common variants in MET have been associated with
ASD across independent cohorts (Campbell et al., 2006, 2008;
Jackson et al., 2009; Sousa et al., 2009; Thanseem et al.,
2010). The ‘‘C’’ variant of rs1858830 is particularly interesting
because it is located in the promoter region of MET and is func-
tional (Campbell et al., 2006, 2008; Jackson et al., 2009). The
presence of the ‘‘C’’ variant reduces nuclear protein binding to
the promoter region, and decreases gene transcription in vitro
by 50% (Campbell et al., 2006). As expected for a common func-
tional variant, the ‘‘C’’ allele correlates with lower levels of MET
transcript and protein expression independent of diagnostic
status (Campbell et al., 2007; Heuer et al., 2011). Common vari-
ants may increase risk but are not ‘‘disorder-causing.’’ Intrigu-
ingly, however, rs1858830 ‘‘C’’ allele moderates the severity of
social symptoms in ASD, whereby individuals with ASD who
carry this risk allele have more severe social and communication
phenotypes than those who do not (Campbell et al., 2010).
The neurobiological correlates of the impact of reduced MET
expression in humans have been examined in Met conditional
knockout (Met-cKO) mice (Judson et al., 2009, 2010; Qiu et al.,
2011). Neocortical pyramidal neurons inMet-cKOmice exhibited
altered dendritic architecture and increased spine head volume
(Judson et al., 2010), as well as a concomitant increase in local
interlaminar excitatory drive onto corticostriatal neurons (Qiu
et al., 2011). This finding of heightened local circuit connectivity
is highly relevant to ASD risk and the current hypothesis
regarding increased local circuit connectivity and decreased
long-range connectivity of brain networks in individuals with
ASD (Belmonte et al., 2004; Just et al., 2004; Courchesne andPierce, 2005; Geschwind and Levitt, 2007). MRI evidence of
long-distance underconnectivity in ASD using both structural
and functional MRI is extensive, and although heterogeneity is
common among ASD and even typically developing (TD)
subjects, some consistent themes have emerged (Vissers
et al., 2012). For example, reduced functional connectivity in
distributed brain networks in ASD has been reported across a
variety of cognitive tasks (e.g., Castelli et al., 2002; Just et al.,
2004; Villalobos et al., 2005; Kleinhans et al., 2008) and when
measuring task-independent (intrinsic) connectivity for inter-
hemispheric (Dinstein et al., 2011; Anderson et al., 2011) and
anterior-posterior connections (Cherkassky et al., 2006; Ken-
nedy and Courchesne, 2008; Monk et al., 2009; Weng et al.,
2010; Assaf et al., 2010; Rudie et al., 2012), particularly within
the default mode network (DMN) (Raichle et al., 2001). The
DMN is involved in socio-emotional processing including men-
talizing and empathizing, which are classically impaired in indi-
viduals with ASD. Additionally, several diffusion tensor imaging
(DTI) studies have reported reduced white matter (WM) integrity
of anterior-posterior and interhemispheric tracts in ASD (Barnea-
Goraly et al., 2004; Alexander et al., 2007; Sundaram et al., 2008;
Shukla et al., 2011). However, DTI studies have been less consis-
tent with regard to the precise tracts involved, with some studies
even reporting tracts with higher fractional anisotropy (FA) in
ASD (Cheung et al., 2009; Cheng et al., 2010; Bode et al.,
2011). Interestingly, a recent study found that unaffected siblings
of individuals with ASD have similar alterations in FA (Barnea-
Goraly et al., 2010), suggesting that the alterations in WM integ-
rity may represent a marker of genetic risk for ASD.
Based on the convergent genetic, clinical, and neurobiological
findings regarding MET as a candidate for mediating ASD risk,
the dramatic restriction of primate neocortical expression to
regions that are implicated in ASD dysfunction (Judson et al.,
2011a; Mukamel et al., 2011), and the functional nature of the
common risk allele in regulating levels of gene expression, we
hypothesized that analysis of the MET promoter variant would
be a powerful tool to examine functional heterogeneity in struc-
tural and functional neuroimaging endophenotypes. We tested
this prediction by examining the relationship between MET risk
genotype and functional activation patterns to social stimuli,
DMN functional connectivity, and the integrity of major WM
tracts. Additionally, we hypothesized that the MET promoter
variant would help address ASD heterogeneity by clustering
a unique subset of individuals with the diagnosis such that indi-
viduals with ASD and the rs1858830MET risk allele would exhibit
the greatest alterations in structural and functional endopheno-
types. In addition to characterizing MET’s role in these circuits,
our findings support a basic strategy of population stratification
with multimodal imaging and genetics that may reveal specific
mechanisms underlying phenotypic heterogeneity.
RESULTS
A total of 162 children and adolescents including 75 with an ASD
and 87 who were TD contributed data to one or more of the three
neuroimaging experiments (see Table S1 available online). This
included a task-based fMRI experiment involving the passive
observation of emotional faces (n = 144), a resting state fMRINeuron 75, 904–915, September 6, 2012 ª2012 Elsevier Inc. 905
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Autism Risk MET Variant Impacts Brain Circuitryscan (n = 71), and a diffusion-weighted scan (n = 84). DNA
was extracted from saliva samples, and the MET variant,
rs1858830, was genotyped by direct resequencing. Individuals
carried zero, one, or two of the rs1858830 C ‘‘risk’’ alleles. There
were three genotype groups: a CC homozygous risk group
(30.2% of sample), a CG heterozygous intermediate-risk
group (49.4% of the sample), and a GG homozygous nonrisk
group (20.3% of the sample). Thus, the terminology (i.e., ‘‘risk’’
versus ‘‘nonrisk’’ group) used hereafter refers to both TD and
ASD individuals with specific MET genotypes. Genotypes
observed Hardy-Weinberg Equilibrium (c2 = 0.001; p = 0.973),
and in this sample we did not observe an enrichment of the
risk allele in individuals with ASD (Fisher’s exact test, p =
0.654). However, it should be noted that our sample, like other
neuroimaging studies, is small for standard genetic association
testing, and the study sample consisted of high-functioning indi-
viduals with ASD. Prior studies have shown an enrichment of the
MET risk allele in individuals with ASD, particularly in multiplex
families (two or more children with ASD; Campbell et al., 2006)
and in the most highly impaired individuals with ASD (Campbell
et al., 2010).
In each of the three data sets, genotype groups did not differ
by age, gender, head motion, IQ, or ASD diagnosis; similarly,
there were no differences between diagnostic groups in age,
gender, or head motion (Table S1). However, consistent with
prior reports by Campbell et al. (2010), ASD homozygous
risk and heterozygous risk groups had significantly higher levels
of social impairment (Autism Diagnostic Observation Schedule
[ADOS], Lord et al., 2000; social subscale, p = 0.001) than the
ASD homozygous nonrisk group. IQ did not differ between the
ASD homozygous nonrisk group and all TD groups (homozygous
risk, heterozygous risk, and homozygous nonrisk) but was signif-
icantly lower in both ASD homozygous risk and heterozygous
risk groups; thus, we included full-scale IQ as a covariate in all
analyses examining the effect of an ASD diagnosis. Additionally,
given that the inheritance pattern (additive, dominant, or reces-
sive) of the genotype effect is not clearly established, for all
data sets we first focused on a direct contrast between the
homozygous risk (CC) and nonrisk (GG) groups collapsed across
diagnostic status (with diagnostic status as a covariate). In addi-
tion, we performed whole-brain analyses comparing TD and
ASD groups collapsed across genotype. Following these initial
whole-brain analyses, we used the regions differing between
the homozygous risk and nonrisk groups as a single region of
interest (ROI) in analyses that included the intermediate geno-
type group and that were further stratified by diagnostic status.
This approach allowed us to compare all possible subgroups
in a sensitive and unbiased fashion.
Functional Activation Patterns to Emotional Faces
We performed fMRI in a cohort of 144 children and adolescents,
including 78 TD (homozygous risk, n = 28; heterozygous risk,
n = 34; homozygous nonrisk, n = 16) and 66 diagnosed with
ASD (homozygous risk, n = 15; heterozygous risk, n = 39; homo-
zygous nonrisk, n = 12; Table S1), during passive observation of
faces displaying different emotions (angry, fearful, happy, sad,
and neutral; with fixation crosses directing attention to the eye
region as previously reported (Dapretto et al., 2006; Pfeifer906 Neuron 75, 904–915, September 6, 2012 ª2012 Elsevier Inc.et al., 2008, 2011). Across all subjects (independent of diag-
nosis), we observed strong correlations between the MET risk
allele and unique patterns of functional brain activity. Remark-
ably, compared to the nonrisk group (n = 28), the risk group
(n = 43) displayed a pattern of hyperactivation and reduced
deactivation in the specific regions in which MET is expressed
in primates and humans (Mukamel et al., 2011; Judson et al.,
2011a; Figure 1A; Table S2). The risk and nonrisk groups both
activated primary/secondary visual cortices, thalamus, and
amygdala; however, the risk group activated amygdala and
striatum more robustly than the nonrisk group. Additionally, the
nonrisk group displayed widespread deactivation (i.e., reduced
activity while viewing faces versus fixation crosses). The deacti-
vation was most prominently displayed in midline structures of
the DMN including the posterior cingulate cortex (PCC) and peri-
sylvian regions centered on primary auditory cortex. In contrast,
the intermediate-risk group did deactivate, but not to the same
extent as the nonrisk group, and the risk group appeared to
show slight activation in these regions on average (Figure 1B).
In a whole-brain comparison between TD and ASD groups, there
was also evidence for reduced deactivation in similar temporal,
frontal, and subcortical regions in individuals with ASD (Fig-
ure S1A). To investigate the risk allele’s inheritance pattern, we
compared the average activity across regions differing between
the risk and nonrisk groups for all three genotype groups strati-
fied into either TD or ASD subgroups. We found that the MET
promoter variant has a differential penetrance between neuro-
typical and autistic individuals. Specifically, TD individuals with
one risk allele showed a similar deactivation pattern to those
without a risk allele (Figure 1B). In contrast, in individuals with
ASD, oneMET risk allele was sufficient to give rise to the atypical
pattern of functional activity, showing less deactivation than the
nonrisk group. In fact, when comparing those with one risk allele,
individuals with ASD exhibited significantly less deactivation in
these regions compared to TD subjects, indicative of an even
more atypical phenotype in the clinical population with the
same MET risk genotype. Consistent with the ROI analysis,
a whole-brain comparison of TD versus ASD subgroups within
the heterozygous risk group found stronger and more wide-
spread differences than those observed when comparing the
TD and ASD groups across genotype (Figure S1B; Table S3).
DMN Functional Connectivity
Based on prior reports of altered DMN function in ASD (Kennedy
et al., 2006; Kennedy and Courchesne, 2008) and MET’s high
expression in the PCC (Judson et al., 2011a), as well as our
finding of atypical DMN deactivation in MET risk carriers, we
next examined the extent towhich theMET functional risk variant
modulates intrinsic DMN functional connectivity. We used
a seed centered in the PCC (Fox et al., 2005) for whole-brain
functional connectivity analyses in rs-fcMRI data in a matched
sample of 33 TD and 38 children and adolescents diagnosed
with ASD. The results were remarkably consistent with the func-
tional activation findings: the MET risk genotype significantly
modulated functional connectivity, such that those in the highest
risk group (CC; n = 16) had reduced intrinsic connectivity
between the PCC and MPFC as well as other nearby regions
in the PCC compared to the nonrisk group (n = 16; Figure 2A;
Figure 1. fMRI Activation Patterns to
Emotional Faces in MET Risk Carriers
(A) Within group whole-brain activation (orange)
and deactivation (blue) maps for CC ‘‘risk’’
group, GG ‘‘nonrisk’’ group, and between groups
(risk > nonrisk; purple).
(B) Averages and SEs for functional activation
parameter estimates from regions in risk > nonrisk
contrast for each genotype phenotype subgroup
(full-scale IQ and MRI scanner included as
covariates in 2X3 ANOVA model). *p < 0.05.
See also Figure S1.
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the heterozygous risk group diagnosed with ASD (n = 24)
showed a pattern of functional connectivity similar to thatNeuron 75, 904–915, Sobserved in the homozygous risk group,
whereas functional connectivity in the
TD heterozygous risk group (n = 15) was
no different than the homozygous nonrisk
group. Collapsed across genotype, the
ASD group exhibited reduced PCC-
MPFC connectivity relative to the TD
group (Figure 2B). A whole-brain analysis
comparing TD and ASD groups indepen-
dent of genotype revealed similar, and
even more extensive, reductions in DMN
connectivity as a function of ASD diag-
nosis (Figure S2B). This diagnostic effect
appeared to be partially driven by a
stronger penetrance of the MET risk
allele in the ASD group, as significant
differences between TD and ASD
subgroups were only observed in risk
carriers (Figure 2B); indeed, MET geno-
type explained 1.7 times as much vari-
ance in DMN connectivity in autistic
relative to neurotypical individuals. Using
an additional seed within the MPFC, we
confirmed that both short- and long-
range intrinsic DMN functional connec-
tivity was reduced as a function of both
MET risk genotype and ASD diagnosis
(Figure S2D; Table S5).
WM Structural Connectivity
To obtain a third line of evidence for the
impact of the MET risk allele on brain
circuitry, we examined the structural
integrity of WM tracts across the whole
brain in a cohort of 84 children and
adolescents (TD, n = 38; ASD, n = 46).
Notably, theMET risk genotype predicted
marked reductions in FA across a
restricted number of major WM tracts
known to connect the very same regions
previously implicated in our functionalconnectivity analyses. Compared to nonrisk allele homozygotes
(n = 19), risk allele homozygotes (n = 23) displayed lower FA in
multiple major tracts in temporo-parieto-occipital regions thateptember 6, 2012 ª2012 Elsevier Inc. 907
Figure 2. Reduced DMN Functional
Connectivity in MET Risk Carriers
(A) DMN connectivity within CC ‘‘risk’’ group,
GG ‘‘nonrisk’’ group, and between groups
(risk > nonrisk; purple).
(B) Averages and SEs for functional connectivity
between posterior cingulate seed and medial
prefrontal and frontal orbital clusters from
GG > CC contrast for each genotype phenotype
subgroup (age and IQ included as covariates in
2X3 ANOVA). *p < 0.05, **p < 0.01.
See also Figure S2.
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the corpus callosum, superior/inferior longitudinal fasciculus,
and cingulum; Figure 3A; Table S6). Consistent with the908 Neuron 75, 904–915, September 6, 2012 ª2012 Elsevier Inc.observed functional connectivity pat-
terns, in these tracts the MET risk allele
had a stronger impact in individuals
with ASD (Figure 3B), explaining nearly
twice (1.9 times) as much variance in the
ASD group. More specifically, ASD
heterozygous risk allele carriers (n = 25)
and homozygous risk allele carriers
(n = 12) both exhibited strong reductions
in FA, whereas structural connectivity
was only significantly impacted in TD
homozygous risk carriers (n = 11). This
was also true for follow-up whole-brain
analyses looking at the additive effect
of the MET risk allele in the TD and
ASD groups independently (Figure S3).
Somewhat surprisingly, whole-brain
analyses directly comparing TD and
ASD groups, independent of genotype,
found relatively minimal reductions in FA
for the ASD compared to TD group (Fig-
ure S3; Table S6).
Correlation between Imaging
and Behavioral Measures
Within the ASD group, we correlated
scores on the ADOS social subscale
(Lord et al., 2000), with measures
derived from the imaging analyses. Lower
levels of deactivation while viewing
emotional expressions, as well as func-
tional and structural connectivity, were
significantly associated with higher levels
of social impairment in the ASD group
overall (Figure S4). However, as previ-
ously noted, we also found a direct rela-
tionship between MET risk genotype
and increased symptom severity within
individuals with ASD. Indeed, the rela-
tionship between brain circuitry and
symptom severity was no longer signifi-cant when covarying for MET risk genotype, suggesting that
MET risk genotype may contribute to both alterations in brain
circuitry and disrupted social behavior.
Figure 3. Reduced WM Integrity in MET
Risk Carriers
(A) Results of TBSS analysis comparing FA in GG
‘‘nonrisk’’ group versus CC ‘‘risk’’ group (p < 0.05,
corrected).
(B) Averages and SEs for FA values in tracts from
nonrisk > risk contrast for each genotype pheno-
type subgroup (age and IQ included as covariates
in 2X3 ANOVA). ***p < 0.001.
See also Figure S3.
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In the present study, we used a multimodal imaging genetics
approach to examine the impact of a common functional variant
inMET on neuroimaging endophenotypes known to be disrupted
in ASD. First, we found that, irrespective of clinical diagnosis,
the functional promoter ‘‘C’’ allele of MET alters functional
activity patterns to social stimuli, DMN functional connectivity,
and WM integrity. Second, individuals with ASD exhibited
similar circuit alterations for all three measures. Third, the MET
risk allele appeared to have a stronger impact across individuals
with ASD, especially within the heterozygous risk group.
Fourth, the most impacted circuits in our study included the
very regions that exhibit the greatest MET expression in the
developing neocortex, including circuits that subserve process-Neuron 75, 904–915, Sing of socially relevant information. And
lastly, measures of structural and func-
tional circuitry correlated with symptom
severity in the expected direction,
although this correlation was driven by
the fact that MET risk genotype was
associated with both increased symptom
severity and alterations in brain circuitry.
These findings highlight a key principle
that is consistent with the concept of
endophenotypes (Gottesman and Gould,
2003), whereby a functional risk allele
predisposing to a disorder will have
a larger impact on disorder-relevant
phenotypes (i.e., relevant to the function
of the gene) than the disorder itself.
Thus, the present data suggest that
taking into account MET risk genotype
will serve as a sound strategy to stratify
individuals with ASD and gain insight
into the neurobiological bases of the
functional heterogeneity that character-
izes ASD (Figure 4).
Functional Activation Patterns
In our analyses, we first focused on func-
tional activation patterns in response to
the passive observation of emotional
facial expressions in a large sample of
66 ASD and 78 TD subjects. The high
expression of MET in ventral temporalcortex, including the amygdala and fusiform gyrus, prompted
us to test whether the ‘‘C’’ risk allele might impact activity in
these regions in response to socially relevant and affect-laden
stimuli. While early studies of emotional face processing docu-
mented amygdala and fusiform hypoactivation in ASD (Baron-
Cohen et al., 2000; Critchley et al., 2000; Schultz et al., 2000),
later studies that better controlled for eye gaze (such as a fixation
cross that directs gaze at the eyes, similar to the one used in the
present study) found either no differences or hyperactivation in
these regions (Hadjikhani et al., 2004; Pierce et al., 2004; Dalton
et al., 2005; Monk et al., 2010). Here, we found that MET risk
genotype was associated with hyperactivation of amygdala
and striatum, as well as the relatively unexpected finding of
reduced deactivation in temporal and midline neocortex. These
latter areas comprise circuits that have the highest METeptember 6, 2012 ª2012 Elsevier Inc. 909
Figure 4. Schematic Depicting a Strategy
for Addressing Phenotypic Heterogeneity
The shading of the ovals indicates variability in
a given phenotypic measure (e.g., brain connec-
tivity). The green outline of the ovals indicates
individuals with a clinical diagnosis (e.g., ASD)
relative to TD controls. Although group differences
on a phenotypic measure may be detected
between a clinical sample and matched controls,
considerable overlap often exists (1). Stratifying
individuals by neuroimaging endophenotypes
independent of diagnosis reveals a continuum
of phenotypes (2). Common risk variants (>5%
of the population) for a disorder (e.g., MET
rs1858830 C/G SNP) may impact brain circuitry
and thus offer a means to stratify populations,
particularly when these variants are functional in
nature (3). Sample stratification by diagnosis and
genotype allows for enhanced parsing of pheno-
typic heterogeneity (4), ultimately providing new
insights into the neural mechanisms underlying
psychiatric disorders.
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2011a; Mukamel et al., 2011). In whole-brain analyses com-
paring TD and ASD groups, we also found evidence for reduced
deactivation in temporal and DMN regions in ASD subjects,
although there were no significant differences in the amygdala
and regions of occipital fusiform gyrus corresponding to the
fusiform face area.
Overall, theMET risk group and ASD subjects (particularly the
intermediate-risk group) showed less deactivation in multiple
cortical and subcortical regions. Deactivation is a less well-
characterized phenomenon in fMRI, but the DMN is known to
show signal decreases in response to a variety of tasks requiring
externally directed attention (Raichle et al., 2001). Interestingly,
task-induced DMN deactivation was shown to have a neuronal
origin (Lin et al., 2011), so it may relate to intrinsic inhibitory
properties of local cortical circuits. Few studies have focused910 Neuron 75, 904–915, September 6, 2012 ª2012 Elsevier Inc.on differences in deactivation in ASD,
but our findings are highly consistent
with those of Kennedy et al. (2006), who
reported that individuals with ASD exhibit
less deactivation within regions of the
DMN. The auditory cortex is also known
to deactivate during visual tasks (Laur-
ienti et al., 2002; Mozolic et al., 2008),
and in our study the auditory cortex
exhibited the strongest deactivation
differences between genotype groups
during this visual task. These findings
of reduced deactivation of perisylvian
and DMN regions in MET risk carriers
may relate to a failure to appropriately
suppress neuronal activity, perhaps
through an enhancement of local connec-
tivity that was influenced by MET during
development, as reported in the Met
mutant mouse by Qiu et al. (2011). Futureimaging and neurophysiological studies are needed to test
this hypothesis.
Functional and Structural Connectivity
The fact thatMET risk carriers displayed altered DMN deactiva-
tion patterns further prompted us to test whether the risk
allele impacts intrinsic functional connectivity in this network,
particularly since DMN connectivity has consistently been
shown to be disrupted in ASD (Cherkassky et al., 2006; Kennedy
and Courchesne, 2008; Monk et al., 2009; Weng et al., 2010;
Assaf et al., 2010; Rudie et al., 2012). Indeed, we found that
MET risk carriers and individuals with ASD exhibited reductions
in long- as well as short-range DMN connectivity. The combina-
tion of reduced deactivation and connectivity supports the
notion that the DMN is both less integrated with itself and less
segregated from other neural systems in both MET risk carriers
Neuron
Autism Risk MET Variant Impacts Brain Circuitryand individuals with ASD (Rudie et al., 2012). Additionally, these
findings suggest that functional alterations in the DMN represent
a trait marker shared in those with, or at risk for, ASD. Future
work should characterize functional connectivity alterations in
other networks as a function of the MET risk allele.
Next, we examined whether structural connectivity was
altered in MET risk carriers, as the MET protein is highly ex-
pressed during axon outgrowth in specificWM tracts in primates
(Judson et al., 2011a). Remarkably, the presence of theMET risk
allele was associated with much stronger disruptions in WM
integrity than having an ASD diagnosis. The effects were most
pronounced in temporo-parietal regions of highMET expression
and especially within the splenium, which includes fiber path-
ways originating from the posterior cingulate/precuneus of the
DMN. This hub region, implicated in all three imaging analyses,
has been characterized as the structural core of the human con-
nectome (Hagmann et al., 2008). The combined array of imaging
findings is consistent with experiments showing the involvement
of MET in neurodevelopmental processes including dendritic
and axon growth and synaptogenesis that underlie circuit devel-
opment (Judson et al., 2011b for review). The reduction in MET
expression due to the functional promoter polymorphism may
affect structure formation and ongoing synaptic function inde-
pendently. Additional work is needed to clarify structure-function
relationships with regard to both MET-mediated and ASD-
general alterations in connectivity.
Enhanced Effect ofMET Risk Allele in ASD
Perhaps most surprisingly, the cumulative data suggest that the
MET ‘‘C’’ risk allele has a greater effect in individuals with ASD.
Beyond the rare, highly penetrant SNVs and CNVs, ASD appears
to have a combinatorial etiology (Geschwind, 2011), likely due
to the influence of other factors that shape circuits underlying
social behavior and communication. Across all three imaging
measures, the neuroimaging endophenotypes of the ASD
intermediate-risk (heterozygote) group were similar to those
observed in the high-risk (homozygote) group, whereas the
neuroimaging phenotypes of the TD intermediate-risk group
resembled those of the nonrisk group. This is consistent with
the notion that multiple genetic and/or environmental factors
contribute to both disrupted MET expression and atypical
circuitry in individuals with ASD. In fact, we previously found
that carriers of a common risk allele in CNTNAP2 also display
alterations in functional and structural connectivity (Scott-Van
Zeeland et al., 2010; Dennis et al., 2011). In addition toCNTNAP2
and MET modulating brain connectivity, transcription of both
genes is regulated by FOXP2 (Vernes et al., 2008; Mukamel
et al., 2011), which is known to pattern speech and language
circuits in humans (Konopka et al., 2009). Consistent with
a multiple-hit model, these findings collectively indicate that in
individuals with ASD, who likely have additional alterations in
the MET signaling pathway, the presence of the MET promoter
risk allele results in more severely impacted brain circuitry and
social behavior.
Relevance to ASD Connectivity Theories
The converging imaging findings reported here provide a mech-
anistic link, through MET disruption, to the previously hypothe-sized relationship between altered local circuit and long-range
network connectivity in ASD (Belmonte et al., 2004; Courchesne
and Pierce, 2005; Geschwind and Levitt, 2007; Qiu et al., 2011).
Moreover, the present results draw a striking parallel with alter-
ations in neuronal architecture and synaptic functioning abnor-
malities found in Met-disrupted mice (Judson et al., 2010; Qiu
et al., 2011). Local circuit hyperconnectivity at the neocortical
microcircuit level seen in conditional Met null/heterozygous
mice may lead to the hyperactivation/reduced deactivation we
observed in humans with MET risk alleles. While speculative at
this point, this may in part account for the presence of enhanced
visual and auditory discrimination (Baron-Cohen et al., 2009;
Jones et al., 2009; Ashwin et al., 2009) or sensory overresponsiv-
ity, observed in some individuals with ASD (Ben-Sasson et al.,
2007; Baranek et al., 2006). Alterations in local circuit connec-
tivity and/or structural connections may ultimately hinder the
typical formation of long-range connectivity (Dosenbach et al.,
2010) as observed in bothMET risk allele carriers and individuals
with ASD.
Addressing Phenotype Overlap and Heterogeneity
in Neurodevelopmental Disorders
We found that structural and functional connectivity was related
to autism symptom severity, particularly in the social domain.
However, this relationship was mediated by the fact that the
MET risk allele was associated with increased symptom severity
and reduced functional and structural connectivity. This result, in
combination with the finding that, across all imaging measures,
TD individuals with two risk alleles exhibited more ‘‘atypical’’
brain circuitry than individuals with ASD carrying no risk alleles,
reveals one possible generalized mechanism for phenotype
overlap that is observed across nonclinical and clinical groups
(Figure 4). This raises critical issues regarding the causal nature
of altered connectivity findings in ASD, and the role of a combina-
tion of genetic and environmental factors that may contribute to
phenotypes that collectively lead to a clinical diagnosis. The idea
that functional and structural alterations may at least in part
reflect genetic vulnerability is also supported by recent studies
showing greater similarity in brain measures between individuals
with ASD and their unaffected siblings than between controls
and unaffected siblings (Kaiser et al., 2010; Spencer et al.,
2011), which is particularly the case for DTI measures (Barnea-
Goraly et al., 2010). The present study highlights the critical
need for future research to take into consideration relevant
genetic factors to parse the heterogeneity present in neurodeve-
lopmental disorders and behavioral phenotypes (Figure 4) to ulti-
mately improve diagnostic or prognostic tools (Fox and Greicius,
2010).
Limitations and Future Directions
Although these findings are useful for developing a more mech-
anistic understanding of the neurobiology of ASD, the present
study focuses on common variation in a single candidate gene.
Future work should characterize the additive effects of, and
interactions between, multiple risk alleles in the context of both
typical and atypical development. Future research should also
attempt to combine different genetic, structural, and functional
measures to test the direction of influence that these may haveNeuron 75, 904–915, September 6, 2012 ª2012 Elsevier Inc. 911
Neuron
Autism Risk MET Variant Impacts Brain Circuitryon one another at the individual level. These types of analyses
will require much larger data sets likely available only through
large-scale collaborative efforts such as the human connectome
project (HCP) (Marcus et al., 2011) and the autism brain imaging
data exchange (ABIDE), a grass roots initiative under the interna-
tional neuroimaging data-sharing initiative (INDI) (Biswal et al.,
2010). Additionally, given that some network alterations are
present in typical individuals who simply carry risk alleles, future
study designs should include unaffected siblings to tease apart
alterations that are related to genetic risk for ASD (i.e., present
in both affected and unaffected siblings) from those that are
specific to actually having the disorder (i.e., present only in
sibling with an ASD diagnosis).
Conclusions
Here, we show how a functional ASD risk allele predisposes to
ASD by affecting functional activity, connectivity, and WM tract
integrity in regions involved in social cognition. This study reports
converging evidence of altered brain function and connectivity
across three different brain measures, both in individuals with
a disorder and those carrying a genetic risk factor for that
disorder. These findings have a number of broad implications.
First, these results reveal an enhanced penetrance of a risk allele
within individuals with ASD, reflecting a mechanism whereby
a common functional variant that is not disorder causing, but in
the context of other factors related to ASD etiology, has a larger
effect on network structure and function than in neurotypical
individuals. Second, given that differences between ASD and
controls were moderated by MET risk genotype and in the
case of functional activity were only revealed when the cohort
was stratified by MET genotype, these data demonstrate the
power of utilizing genetic data for understanding and parsing
phenotypic heterogeneity in ASD as well as other neuropsychi-
atric disorders characterized by considerable heterogeneity
(e.g., Rasetti and Weinberger, 2011; Figure 4). This approach
may provide a more sensitive means to identify subgroups of
individuals with particular risk alleles and brain circuitry for
whom targeted treatments may be developed. Finally, expand-
ing upon our prior findings linking a CNTNAP2 common variant
to brain connectivity (Scott-Van Zeeland et al., 2010; Dennis
et al., 2011), the discovery that theMET risk allele has large effect
sizes on structural and functional brain circuitry in both typical
and atypical development indicates that some alterations in
brain networks in ASD may, in part, reflect genetic vulnerability,
or liability, rather than causal mechanisms. Taken together, the
current results indicate that considering relevant genetic factors
when interpreting neuroimaging data will greatly aid in under-
standing, and ultimately treating, ASD and other clinically and
genetically heterogeneous neuropsychiatric disorders.
EXPERIMENTAL PROCEDURES
Subjects
High-functioning children and adolescents with ASD and TD children were re-
cruited from the greater Los Angeles area to participate in this study. Informed
consent and assent to participate were obtained prior to assessment under
our institutional review board-approved protocols. Details regarding recruit-
ment, consent, and sample demographics are included in Supplemental
Experimental Procedures and Table S1.912 Neuron 75, 904–915, September 6, 2012 ª2012 Elsevier Inc.Genotyping
Subjects provided saliva samples for genetic analysis. DNA was isolated from
saliva using standard protocols from the OraGene Collection Kit (DNA Geno-
Tek, Ontario, Canada). Genotypes at rs1858830 were determined by direct
sequencing, as described elsewhere by Campbell et al. (2007) and detailed
in the Supplemental Experimental Procedures.
MRI Data Acquisition
A total of 75 individuals with ASD and 87 TD individuals were included in at
least one of the three data sets (fMRI, rs-fcMRI, and DTI) detailed in Table
S1. The fMRI data were collected across two different scanners (Siemens 3T
Trio and Siemens 3T Allegra), while all of the DTI and rs-fcMRI data were
collected on a Siemens 3T Trio scanner. See Supplemental Experimental
Procedures for MRI acquisition details.
fMRI Task Data Analysis
Participants underwent a rapid event-related fMRI paradigm in which they
simply observed faces displaying different emotions (see Dapretto et al.,
2006; Pfeifer et al., 2008, 2011). These data underwent standard fMRI prepro-
cessing including motion correction, brain extraction, spatial smoothing, and
normalization to standard space. The contrast of all emotional faces versus
null events was examined at the group level using a mixed effects model.
See Supplemental Experimental Procedures for further details.
rs-fcMRI Data Analysis
In a single resting state session, subjects were told to relax and keep their
eyes open while a fixation cross was displayed on a white background for
6 min. In addition to all of the preprocessing steps described above for the
task-related fMRI scan, we band-pass filtered (0.1 Hz > t > 0.01 Hz) the data
and regressed out nuisance covariates, including six rigid body motion
parameters, volumes corresponding to motion spikes, and averageWM, cere-
brospinal fluid (CSF), and global time series. Average time series from 5 mm
radius spheres in the PCC and MPFC within the DMN (Fox et al., 2005) were
correlated with every voxel in the brain to generate connectivity maps for
each subject, which were compared between participants using ordinary
least-squares regression. See Supplemental Experimental Procedures for
further details.
DTI Data Analysis
We examined FA across the whole brain using Tract-Based Spatial Statistics
(TBSS version 1.2; Smith et al., 2006). Data analysis consisted of removal
of images with gross artifacts, motion and eddy current correction, brain
extraction, fitting a tensor model and calculating FA at each voxel, nonlinear
registration to a template brain in standard space, skeletonization of tracts,
and voxel-wise inference testing through permutation testing as implemented
with Randomise. See Supplemental Experimental Procedures for further
details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, six tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.neuron.2012.07.010.
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